Sarepta Therapeutics
SRPT
#5165
Rank
โ‚น166.25 B
Marketcap
โ‚น1,550
Share price
0.79%
Change (1 day)
1.20%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Earnings for Sarepta Therapeutics (SRPT)

Earnings in 2026 (TTM): -โ‚น10.31 Billion

According to Sarepta Therapeutics 's latest financial reports the company's current earnings are โ‚น1.97 Billion. In 2025 the company made an earning of -โ‚น65.79 Billion a decrease over its 2024 earnings that were of โ‚น24.42 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sarepta Therapeutics from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น10.31 Billion-84.33%
2025 -โ‚น65.79 Billion-369.28%
2024 โ‚น24.42 B-150.14%
2023 -โ‚น48.73 Billion-24.62%
2022 -โ‚น64.64 Billion64.69%
2021 -โ‚น39.25 Billion-24.25%
2020 -โ‚น51.82 Billion-22.53%
2019 -โ‚น66.88 Billion96.87%
2018 -โ‚น33.97 Billion645.68%
2017 -โ‚น4.56 Billion-81.81%
2016 -โ‚น25.04 Billion21.47%
2015 -โ‚น20.62 Billion62.04%
2014 -โ‚น12.73 Billion21.26%
2013 -โ‚น10.5 Billion60.93%
2012 -โ‚น6.52 Billion93.69%
2011 -โ‚น3.37 Billion71.58%
2010 -โ‚น1.97 Billion35.06%
2009 -โ‚น1.46 Billion-11.62%
2008 -โ‚น1.65 Billion-47.02%
2007 -โ‚น3.11 Billion0.38%
2006 -โ‚น3.09 Billion88.3%
2005 -โ‚น1.65 Billion-30.06%
2004 -โ‚น2.35 Billion32.69%
2003 -โ‚น1.77 Billion-25.52%
2002 -โ‚น2.38 Billion64.52%
2001 -โ‚น1.45 Billion50.4%
2000 -โ‚น0.96 Billion26.44%
1999 -โ‚น0.76 Billion8%
1998 -โ‚น0.71 Billion102.7%
1997 -โ‚น0.35 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
-โ‚น237.3 Billion 1,834.77%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-โ‚น7.98 Billion-35.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚น20.93 Billion 70.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น114.42 B-1,032.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
-โ‚น48.94 Billion 298.99%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น33.24 Billion 170.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-โ‚น64.14 Billion 422.94%๐Ÿ‡บ๐Ÿ‡ธ USA